R&D Top 30: A look at R&D investments in the Netherlands

New Approach: Recognizing International Players in Local R&D

For the 2024 edition, the criteria have shifted to include R&D activities conducted in the Netherlands, regardless of a company’s headquarters location. This acknowledges the contributions of global companies, such as Airbus and Johnson & Johnson, whose Dutch operations significantly advance technology and knowledge.

Top Performers and Notable Contributors

Once again, ASML leads the list with €2.8 billion spent on R&D in the Netherlands in 2023, maintaining its position as the dominant force in semiconductor development. Other companies, including Philips, Booking Holdings, and Johnson & Johnson, also demonstrate firm R&D commitments. While Johnson & Johnsonranks fifth in Dutch spending, its global R&D efforts far surpass those of other companies on the list, reaching €11.1 billion.

Leiden Bio Science Park and Its Role in Research

Situated in a region known for fostering innovation, Leiden Bio Science Park is home to both global leaders like Johnson & Johnson and emerging biotech ventures. This environment encourages collaboration across industries, particularly in biotechnology, healthcare, and aerospace.

Shifting Trends in R&D Investment

The R&D Top 30 reflects the evolving priorities of businesses operating in the Netherlands. The growth in sectors like digital transformation and biotechnology underscores the importance of a strong research foundation. Companies like Airbus Netherlands and Johnson & Johnson exemplify how local investments contribute to global challenges.

The return of the R&D Top 30 provides a renewed opportunity to assess and celebrate the R&D activity shaping the Netherlands. For those curious about the complete list, the 2024 rankings reveal the breadth and depth of research taking place across industries.